Remove 2023 Remove Clinic Remove Disease
article thumbnail

Diagnosing Pediatric Crohn Disease With Radiomic and Clinical Data

Imaging Technology

milla1cf Wed, 08/02/2023 - 19:58 August 2, 2023 — An accepted manuscript published in the American Journal of Roentgenology (AJR) found that deploying a radiomic-based model with T2-weighted MRI data could increase diagnostic accuracy for pediatric Crohn disease (CD). Dillman , MD, MSc. Dillman et al.’s and accuracy of 89.6%.

article thumbnail

PET reveals patient responses to new Alzheimer’s disease drug

AuntMinnie

Patients with less tau pathology on PET scans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Food and Drug Administration, with a decision expected by the end of 2023. Donanemab is currently under review for approval by the U.S.

Disease 119
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Study on Value of 68Ga-FAPI PET/CT Imaging for Evaluation of Disease Activity in Rheumatoid Arthritis presented during SNMMI 2023

Imaging Technology

christine.book Mon, 06/26/2023 - 12:46 June 26, 2023 — PET imaging with 68Ga-FAPI offers a feasible, reliable, and reproducible method for evaluating disease activity in rheumatoid arthritis, according to new research presented at the 2023 Society of Nuclear Medicine and Molecular Imaging Annual Meeting.

Disease 98
article thumbnail

Research Showing Genomics- and Image-Guided Subtyping Refines Characterization of Alzheimer’s Disease Presented at SNMMI 2023

Imaging Technology

Based on a novel clustering framework using sparse canonical correlation analysis (SCCA), the integrated approach was successful in identifying four subtypes of Alzheimer’s disease and the top genes associated with each, according to the authors of the study, “An SCCA-clustering framework for Alzheimer’s disease subtyping using tau PET and genomics.”

Disease 97
article thumbnail

Road to RSNA 2023: AI Preview

AuntMinnie

Welcome to the first installment of this year’s Road to RSNA preview of the RSNA 2023 meeting. AI’s capability and potential to enhance the practice of radiology will take center stage at RSNA 2023. For more information on those presentations and other abstracts, check out the RSNA 2023 meeting program. 9:40 a.m. | 9:40 a.m. |

article thumbnail

Magnetic Resonance-guided Focused Ultrasound in Intracranial Diseases

Imaging Technology

Food and Drug Administration has approved this technology for the treatment of essential tremor and Parkinson's disease, and its indications are expanding to include various intracranial diseases. High-intensity FUS is a safe and effective treatment for various intracranial diseases.

Disease 105
article thumbnail

Research Spotlight: Validating an MRI Biomarker for Early Onset Alzheimer’s Disease

Imaging Technology

Is there a signature biomarker for younger/early-onset Alzheimer’s Disease (EOAD)? Sporadic early-onset Alzheimer’s disease (EOAD) is rare and understudied. What Are the Clinical Implications? We were able to prove that the EOAD signature is a clinically valid measure of AD-related neurodegeneration.

Disease 111